+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In Vitro Diagnostic Market Research Report: By Offering, Technology, Application, End User - Global Industry Analysis and Growth Forecast to 2030

  • ID: 5229087
  • Report
  • October 2020
  • Region: Global
  • 344 pages
  • Prescient & Strategic Intelligence Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Grifols S.A.
  • OraSure Technologies Inc.
  • MORE
The global in-vitro diagnostic (IVD) market reached a valuation of $63.5 billion in 2019 and is predicted to progress at a CAGR of 6.6% between 2020 and 2030. According to the report estimates, a market research firm based in India, the market would generate a revenue of $127.4 billion by 2030. The key factor driving the progress of the market is the rising enactment of strict regulations and policies in several countries regarding blood sample contamination.

Besides the aforementioned factor, the growing incidence of chronic diseases, the surging number of blood donors, rapid advancements and innovations in the IVD technology, the increasing number of academic institutions and hospitals, and soaring healthcare expenditure in various countries are also fueling the expansion of the in-vitro diagnostic market across the world. As per the International Diabetes Federation (IDF) Atlas 9th edition, 352 million people in the age group 20 - 64 were diagnosed with diabetes in 2019.

Furthermore, this number is predicted to grow to 486 million by 2045. As per the findings of the World Health Organization (WHO), cancer claimed as many as 9.6 million lives in 2018. The Joint United Nations Programme on HIV/AIDS (UNAIDS) found that 37.9 million people around the world suffered from HIV/AIDS in 2018. The high occurrence of these diseases is boosting the demand for IVD testing, which is, in turn, propelling the growth of the market.

Based on offering, the in-vitro diagnostic market is divided into software & services, instruments, and reagents & kits. Out of these, the reagents & kits category is predicted to dominate the market in the future years. The increasing number of IVD tests being performed all over the world, because of the ballooning prevalence of infectious and chronic diseases and the surging number of research activities, is driving the advancement of this category in the market in the forthcoming years.

Geographically, the in-vitro diagnostic market is predicted to exhibit the fastest growth in the Asia-Pacific (APAC) region in the upcoming years. This would be because of the existence of leading market players in the region and their focus on various strategic development activities in order to improve their market position. For example, according to Abbott Laboratories, in October 2019, the Australian Red Cross Blood Service signed a multi-year agreement for Alinity system, the organization’s plasma and blood screening technology.

Hence, it can be said without any hesitation that the market would boom in the future years, primarily because of the increasing requirement for blood donations and the growing enactment of several strict policies regarding blood contamination in several countries around the world.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Grifols S.A.
  • OraSure Technologies Inc.
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Offering
1.3.2 Market Segmentation by Technology
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.3.7.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Offering
4.1.1.1 Reagents & kits
4.1.1.2 Instruments
4.1.1.3 Software & services
4.1.2 By Technology
4.1.2.1 Clinical chemistry
4.1.2.1.1 Basic metabolic panel
4.1.2.1.2 Lipid profile
4.1.2.1.3 Liver profile
4.1.2.1.4 Renal profile
4.1.2.1.5 Thyroid function panel
4.1.2.1.6 Others
4.1.2.2 Immunochemistry
4.1.2.2.1 ELISA
4.1.2.2.2 RIA
4.1.2.2.3 FIA
4.1.2.2.4 CLIA
4.1.2.2.5 ICA
4.1.2.2.6 Others
4.1.2.3 Molecular diagnostics
4.1.2.3.1 Infectious diseases
4.1.2.3.2 Genomics
4.1.2.3.3 Blood donor screening
4.1.2.3.4 Others
4.1.2.4 Hematology
4.1.2.4.1 CBC
4.1.2.4.2 Cholesterol testing
4.1.2.4.3 Blood glucose testing
4.1.2.4.4 Hemoglobin testing
4.1.2.4.5 Coagulation testing
4.1.2.4.6 Others
4.1.2.5 Others
4.1.3 By Application
4.1.3.1 Infectious diseases
4.1.3.2 Diabetes
4.1.3.3 Oncology
4.1.3.4 Cardiology
4.1.3.5 Nephrology
4.1.3.6 Autoimmune diseases
4.1.3.7 Others
4.1.4 By End User
4.1.4.1 Hospitals & clinics
4.1.4.2 POC
4.1.4.3 Research & academic institutes
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Approval and launch of new products
4.2.1.2 Increasing number of collaborations and agreements
4.2.2 Drivers
4.2.2.1 Regulations with respect to blood safety and sample contamination
4.2.2.2 Surging burden of chronic diseases
4.2.2.3 Increasing number of blood donors
4.2.2.4 Advancements in IVD technology
4.2.2.5 Increasing healthcare expenditure
4.2.2.6 Increasing number of hospitals and academic institutes
4.2.2.7 Impact analysis of drivers on the market forecast period
4.2.3 Restraints
4.2.3.1 Challenges in maintaining sufficient, safe sample supply
4.2.3.2 Data insecurity over donors’ demographic information
4.2.3.3 Cost-ineffectiveness of IVD products
4.2.3.4 Impact analysis of restraints on the market forecast
4.3 Porter’s Five Forces Analysis
4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast
5.1 By Offering
5.2 By Technology
5.2.1 IVD Market for Clinical Chemistry, by Type
5.2.2 IVD Market for Immunochemistry, by Type
5.2.3 IVD Market for Molecular Diagnostics, by Type
5.2.4 IVD Market for Hematology, by Type
5.3 By Application
5.4 By End User
5.5 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Offering
6.2 By Technology
6.2.1 IVD Market for Clinical Chemistry, by Type
6.2.2 IVD Market for Immunochemistry, by Type
6.2.3 IVD Market for Molecular Diagnostics, by Type
6.2.4 IVD Market for Hematology, by Type
6.3 By Application
6.4 By End User
6.5 By Country
6.5.1 U.S. Market Size and Forecast
6.5.1.1 By offering
6.5.1.2 By technology
6.5.1.2.1 IVD market for clinical chemistry, by type
6.5.1.2.2 IVD market for immunochemistry, by type
6.5.1.2.3 IVD market for molecular diagnostics, by type
6.5.1.2.4 IVD market for hematology, by type
6.5.1.3 By application
6.5.1.4 By end user
6.5.2 Canada Market Size and Forecast
6.5.2.1 By offering
6.5.2.2 By technology
6.5.2.2.1 IVD market for clinical chemistry, by type
6.5.2.2.2 IVD market for immunochemistry, by type
6.5.2.2.3 IVD market for molecular diagnostics, by type
6.5.2.2.4 IVD market for hematology, by type
6.5.2.3 By application
6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast
7.1 By Offering
7.2 By Technology
7.2.1 IVD Market for Clinical Chemistry, by Type
7.2.2 IVD Market for Immunochemistry, by Type
7.2.3 IVD Market for Molecular Diagnostics, by Type
7.2.4 IVD Market for Hematology, by Type
7.3 By Application
7.4 By End User
7.5 By Country
7.5.1 Germany Market Size and Forecast
7.5.1.1 By offering
7.5.1.2 By technology
7.5.1.2.1 IVD market for clinical chemistry, by type
7.5.1.2.2 IVD market for immunochemistry, by type
7.5.1.2.3 IVD market for molecular diagnostics, by type
7.5.1.2.4 IVD market for hematology, by type
7.5.1.3 By application
7.5.1.4 By end user
7.5.2 France Market Size and Forecast
7.5.2.1 By offering
7.5.2.2 By technology
7.5.2.2.1 IVD market for clinical chemistry, by type
7.5.2.2.2 IVD market for immunochemistry, by type
7.5.2.2.3 IVD market for molecular diagnostics, by type
7.5.2.2.4 IVD market for hematology, by type
7.5.2.3 By application
7.5.2.4 By end user
7.5.3 Italy Market Size and Forecast
7.5.3.1 By offering
7.5.3.2 By technology
7.5.3.2.1 IVD market for clinical chemistry, by type
7.5.3.2.2 IVD market for immunochemistry, by type
7.5.3.2.3 IVD market for molecular diagnostics, by type
7.5.3.2.4 IVD market for hematology, by type
7.5.3.3 By application
7.5.3.4 By end user
7.5.4 Spain Market Size and Forecast
7.5.4.1 By offering
7.5.4.2 By technology
7.5.4.2.1 IVD market for clinical chemistry, by type
7.5.4.2.2 IVD market for immunochemistry, by type
7.5.4.2.3 IVD market for molecular diagnostics, by type
7.5.4.2.4 IVD market for hematology, by type
7.5.4.3 By application
7.5.4.4 By end user
7.5.5 U.K. Market Size and Forecast
7.5.5.1 By offering
7.5.5.2 By technology
7.5.5.2.1 IVD market for clinical chemistry, by type
7.5.5.2.2 IVD market for immunochemistry, by type
7.5.5.2.3 IVD market for molecular diagnostics, by type
7.5.5.2.4 IVD market for hematology, by type
7.5.5.3 By application
7.5.5.4 By end user

Chapter 8. APAC Market Size and Forecast
8.1 By offering
8.2 By Technology
8.2.1 IVD Market for Clinical Chemistry, by Type
8.2.2 IVD Market for Immunochemistry, by Type
8.2.3 IVD Market for Molecular Diagnostics, by Type
8.2.4 IVD Market for Hematology, by Type
8.3 By Application
8.4 By End User
8.5 By Country
8.5.1 China Market Size and Forecast
8.5.1.1 By offering
8.5.1.2 By technology
8.5.1.2.1 IVD market for clinical chemistry, by type
8.5.1.2.2 IVD market for immunochemistry, by type
8.5.1.2.3 IVD market for molecular diagnostics, by type
8.5.1.2.4 IVD market for hematology, by type
8.5.1.3 By application
8.5.1.4 By end user
8.5.2 Japan Market Size and Forecast
8.5.2.1 By offering
8.5.2.2 By technology
8.5.2.2.1 IVD market for clinical chemistry, by type
8.5.2.2.2 IVD market for immunochemistry, by type
8.5.2.2.3 IVD market for molecular diagnostics, by type
8.5.2.2.4 IVD market for hematology, by type
8.5.2.3 By application
8.5.2.4 By end user
8.5.3 India Market Size and Forecast
8.5.3.1 By offering
8.5.3.2 By technology
8.5.3.2.1 IVD market for clinical chemistry, by type
8.5.3.2.2 IVD market for immunochemistry, by type
8.5.3.2.3 IVD market for molecular diagnostics, by type
8.5.3.2.4 IVD market for hematology, by type
8.5.3.3 By application
8.5.3.4 By end user

Chapter 9. LATAM Market Size and Forecast
9.1 By offering
9.2 By Technology
9.2.1 IVD Market for Clinical Chemistry, by Type
9.2.2 IVD Market for Immunochemistry, by Type
9.2.3 IVD Market for Molecular Diagnostics, by Type
9.2.4 IVD Market for Hematology, by Type
9.3 By Application
9.4 By End User
9.5 By Country
9.5.1 Brazil Market Size and Forecast
9.5.1.1 By offering
9.5.1.2 By technology
9.5.1.2.1 IVD market for clinical chemistry, by type
9.5.1.2.2 IVD market for immunochemistry, by type
9.5.1.2.3 IVD market for molecular diagnostics, by type
9.5.1.2.4 IVD market for hematology, by type
9.5.1.3 By application
9.5.1.4 By end user
9.5.2 Mexico Market Size and Forecast
9.5.2.1 By offering
9.5.2.2 By technology
9.5.2.2.1 IVD market for clinical chemistry, by type
9.5.2.2.2 IVD market for immunochemistry, by type
9.5.2.2.3 IVD market for molecular diagnostics, by type
9.5.2.2.4 IVD market for hematology, by type
9.5.2.3 By application
9.5.2.4 By end user

Chapter 10. MEA Market Size and Forecast
10.1 By offering
10.2 By Technology
10.2.1 IVD Market for Clinical Chemistry, by Type
10.2.2 IVD Market for Immunochemistry, by Type
10.2.3 IVD Market for Molecular Diagnostics, by Type
10.2.4 IVD Market for Hematology, by Type
10.3 By Application
10.4 By End User
10.5 By Country
10.5.1 Saudi Arabia Market Size and Forecast
10.5.1.1 By offering
10.5.1.2 By technology
10.5.1.2.1 IVD market for clinical chemistry, by type
10.5.1.2.2 IVD market for immunochemistry, by type
10.5.1.2.3 IVD market for molecular diagnostics, by type
10.5.1.2.4 IVD market for hematology, by type
10.5.1.3 By application
10.5.1.4 By end user
10.5.2 South Africa Market Size and Forecast
10.5.2.1 By offering
10.5.2.2 By technology
10.5.2.2.1 IVD market for clinical chemistry, by type
10.5.2.2.2 IVD market for immunochemistry, by type
10.5.2.2.3 IVD market for molecular diagnostics, by type
10.5.2.2.4 IVD market for hematology, by type
10.5.2.3 By application
10.5.2.4 By end user

Chapter 11. Competitive Landscape
11.1 Global IVD Market Share of Key Players
11.2 Strategic Developments of Key Players
11.2.1 Product Launches and Approvals
11.2.2 Mergers and Acquisitions
11.2.3 Other Developments

Chapter 12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Danaher Corporation
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 PerkinElmer Inc.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Quidel Corporation
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 OraSure Technologies Inc.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Sysmex Corporation
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 DIAGNOSTICA STAGO S.A.S
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Siemens AG
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.9.3 Key Financial Summary
12.10 Abbott Laboratories
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.11 Becton, Dickinson and Company
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Hologic Inc.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.12.3 Key Financial Summary
12.13 Sartorius Stedim Biotech S.A.
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.13.3 Key Financial Summary
12.14 Bio-Rad Laboratories Inc.
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.14.3 Key Financial Summary
12.15 bioMérieux S.A.
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.15.3 Key Financial Summary
12.16 Trinity Biotech plc
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.16.3 Key Financial Summary
12.17 Bio-Techne Corporation
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.17.3 Key Financial Summary
12.18 DiaSorin S.p.A.
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.18.3 Key Financial Summary
12.19 Ortho-Clinical Diagnostics Inc.
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.20 Grifols S.A.
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.20.3 Key Financial Summary

Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports

List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL IVD MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL IVD MARKET SNAPSHOT (2019)
FIG 15 GLOBAL IVD MARKET, BY OFFERING, $M (2014-2030)
FIG 16 GLOBAL IVD MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 17 GLOBAL IVD MARKET, BY APPLICATION, $M (2014-2030)
FIG 18 GLOBAL IVD MARKET, BY END USER, $M (2014-2030)
FIG 19 GLOBAL IVD MARKET, BY REGION, $M (2014-2030)
FIG 20 NORTH AMERICA IVD MARKET SNAPSHOT
FIG 21 NORTH AMERICA IVD MARKET, BY OFFERING, $M (2014-2030)
FIG 22 NORTH AMERICA IVD MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 23 NORTH AMERICA IVD MARKET, BY APPLICATION, $M (2014-2030)
FIG 24 NORTH AMERICA IVD MARKET, BY END USER, $M (2014-2030)
FIG 25 NORTH AMERICA IVD MARKET, BY COUNTRY, $M (2014-2030)
FIG 26 EUROPE IVD MARKET SNAPSHOT
FIG 27 EUROPE IVD MARKET, BY OFFERING, $M (2014-2030)
FIG 28 EUROPE IVD MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 29 EUROPE IVD MARKET, BY APPLICATION, $M (2014-2030)
FIG 30 EUROPE IVD MARKET, BY END USER, $M (2014-2030)
FIG 31 EUROPE IVD MARKET, BY COUNTRY, $M (2014-2030)
FIG 32 APAC IVD MARKET SNAPSHOT
FIG 33 APAC IVD MARKET, BY OFFERING, $M (2014-2030)
FIG 34 APAC IVD MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 35 APAC IVD MARKET, BY APPLICATION, $M (2014-2030)
FIG 36 APAC IVD MARKET, BY END USER, $M (2014-2030)
FIG 37 APAC IVD MARKET, BY COUNTRY, $M (2014-2030)
FIG 38 LATAM IVD MARKET SNAPSHOT
FIG 39 LATAM IVD MARKET, BY OFFERING, $M (2014-2030)
FIG 40 LATAM IVD MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 41 LATAM IVD MARKET, BY APPLICATION, $M (2014-2030)
FIG 42 LATAM IVD MARKET, BY END USER, $M (2014-2030)
FIG 43 LATAM IVD MARKET, BY COUNTRY, $M (2014-2030)
FIG 44 MEA IVD MARKET SNAPSHOT
FIG 45 MEA IVD MARKET, BY OFFERING, $M (2014-2030)
FIG 46 MEA IVD MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 47 MEA IVD MARKET, BY APPLICATION, $M (2014-2030)
FIG 48 MEA IVD MARKET, BY END USER, $M (2014-2030)
FIG 49 MEA IVD MARKET, BY COUNTRY, $M (2014-2030)
FIG 50 GLOBAL IVD MARKET SHARE OF KEY PLAYERS, 2019
FIG 51 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 52 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 53 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 54 PERKINELMER INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 55 QUIDEL CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 56 ORASURE TECHNOLOGIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 57 SYSMEX CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
FIG 58 SIEMENS AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 59 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 60 BECTON, DICKINSON AND COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 61 HOLOGIC INC. - REVENUE SPLIT BY PRODUCT SEGMENT AND GEOGRAPHY (2019)
FIG 62 SARTORIUS STEDIM BIOTECH S.A. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 63 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 64 BIOMÉRIEUX S.A. - REVENUE SPLIT BY APPLICATION AND GEOGRAPHY (2018)
FIG 65 TRINITY BIOTECH PLC. - REVENUE SPLIT BY SEGMENT (2018)
FIG 66 BIO-TECHNE CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 67 DIASORIN S.P.A. - REVENUE SPLIT BY TECHNOLOGY AND GEOGRAPHY (2018)
FIG 68 GRIFOLS S.A. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
3 of 4
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Quidel Corporation
  • OraSure Technologies Inc.
  • Sysmex Corporation
  • DIAGNOSTICA STAGO S.A.S
  • Siemens AG
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic Inc.
  • Sartorius Stedim Biotech S.A.
  • Bio-Rad Laboratories Inc.
  • bioMérieux S.A.
  • Trinity Biotech plc
  • Bio-Techne Corporation
  • DiaSorin S.p.A.
  • Ortho-Clinical Diagnostics Inc.
  • Grifols S.A.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll